Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,471 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

NCT07326566

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +19 more
Locations
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Recruiting

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

NCT06556563

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 102 locations
View Trial Details
Recruiting

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

NCT07225621

Conditions
Astrocytoma, GBM, Glioblastoma, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Albany Medical Center Albany, New York, United States
  • Dent Neurologic Institute Buffalo, New York, United States
View Trial Details

Related conditions